Stocks · Health care · Biological Products, (No Diagnostic Substances)

Vir Biotechnology, Inc.

VIR Clue Score34

United States Fiscal year ends December CIK 0001706431 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

By person

18 insiders · 34 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

SVF Endurance (Cayman) Ltd entity

10% owner

—

$5.27M (5) scheduled

−$5.27M

13,728,924

8.11%

$152.39M

−17.7%

Vicki L Sato

Director

—

$1.48M (9) scheduled

−$1.48M

1,078,391

0.6373%

$11.97M

−18.5%

Backer Marianne De

President and CEO

—

$946.96K (3) scheduled

−$946.96K

1,001,263

0.5917%

$11.11M

+47.6%

Verneuil Vanina de

EVP, General Counsel, Corp Sec

—

$239.31K (5) scheduled

−$239.31K

110,193

0.0651%

$1.22M

+67.1%

Brent Sabatini

SVP, Chief Accounting Officer

—

$113.09K (5) scheduled

−$113.09K

61,902

0.0366%

$687.11K

+88.1%

Jason O'Byrne

EVP & Chief Financial Officer

—

$68.93K (3) scheduled

−$68.93K

162,615

0.0961%

$1.81M

+5,084%

Mark Eisner

EVP and Chief Medical Officer

—

$49.52K (3) scheduled

−$49.52K

154,024

0.0910%

$1.71M

+105.4%

Janet Napolitano

Director

—

$30.24K (1) scheduled

−$30.24K

21,216

0.0125%

$235.50K

+82.6%

George A Scangos

Director

—

—

—

698,239

0.4126%

$7.75M

−2.9%

Robert J More

Director

—

—

—

558,573

0.3301%

$6.20M

+2.9%

Ann M. Hanly

EVP & Chief Technology Officer

—

—

—

117,901

0.0697%

$1.31M

−10.7%

Charles Elliott Sigal

Director

—

—

—

39,806

0.0235%

$441.85K

+67.2%

Jeffrey S. Hatfield

Director

—

—

—

39,806

0.0235%

$441.85K

+67.2%

Ramy Farid

Director

—

—

—

32,000

0.0189%

$355.20K

+100.0%

Norbert W Bischofberger

Director

—

—

—

32,000

0.0189%

$355.20K

+100.0%

Saira Ramasastry

Director

—

—

—

22,619

0.0134%

$251.07K

+54.7%

Timothy Coughlin

Director

—

—

—

16,000

0.0095%

$177.60K

—

Suzanne Louise Topalian

Director

—

—

—

12,731

0.0075%

$141.31K

—